Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medpace

304.39
-0.8900-0.29%
Volume:34.15K
Turnover:10.43M
Market Cap:9.27B
PE:24.10
High:307.00
Open:305.28
Low:303.90
Close:305.28
Loading ...

Company Profile

Company Name:
Medpace
Exchange:
NASDAQ
Establishment Date:
1992
Employees:
5900
Office Location:
5375 Medpace Way,Cincinnati,Ohio,United States
Zip Code:
45227
Fax:
513 579 0444
Introduction:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Directors

Name
Position
August J. Troendle
President, Chief Executive Officer and Chairman of the Board
Fred B. Davenport, Jr.
Lead Director
Ashley M. Keating
Director
Brian T. Carley
Director
Cornelius P. McCarthy III
Director
Robert O. Kraft
Director
Thomas C. King
Director

Shareholders

Name
Position
August J. Troendle
President, Chief Executive Officer and Chairman of the Board
Jesse J. Geiger
Chief Financial Officer and Chief Operating Officer, Laboratory Operations
Stephen P. Ewald
General Counsel and Corporate Secretary
Susan E. Burwig
Executive Vice President, Operations